The Ramaciotti Foundations give $1.6 million to biomedical research
As trustee of the Ramaciotti Foundations, Perpetual hosted the Ramaciotti Awards on 4 November 2010, where over $1.6 million was given to biomedical research. The Awards provide assistance to scientists in areas such as molecular biology, genetics and immunology, and assist young investigators taking up new challenges in biomedical research.
Established by Vera Ramaciotti in 1970, the Ramaciotti Foundations are managed by Perpetual and are one of the largest private contributors to biomedical research in Australia. They make significant distributions each year through the Ramaciotti Awards. This year, they celebrate their 40th anniversary, having granted more than $48 million to research projects since their establishment.
Immunisation researcher Professor Christopher Goodnow wins Ramaciotti Medal
Professor Christopher Goodnow from the Australian National University was awarded the prestigious Ramaciotti Medal for Excellence in Biomedical Research. The Ramaciotti Medal carries a $50,000 prize and recognises an outstanding contribution to clinical or biomedical research, or the way in which healthcare is delivered.
Professor Goodnow was awarded the Medal for his research into how the immune system is controlled so that it does not attack our own organs and tissues when it repels invading bacteria and viruses. His work will enable scientists to develop more effective drugs for treatment of a wide range of conditions, from infectious diseases to diabetes and cancer.
Read the full media release.
Find out more
Visit the Ramaciotti Awards website for more information about the Awards, including how to apply for funding.
You can also read more about how to create a philanthropic legacy.
Perpetual’s Philanthropic Services and advice are provided by Perpetual Trustee Company Limited (PTCo), ABN 42 000 001 007, AFSL 236643. This has been prepared by PTCo and contains information contributed by third parties. The information is believed to be accurate at the time of compilation and is provided by PTCo in good faith. To the extent permitted by law, no liability is accepted for any loss or damage as a result of any reliance on this information. PTCo does not warrant the accuracy or completeness of any information included in this document which was contributed by a third party.
